Counseling program to improve opioid treatment in Cherokee Nation
Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation
NA · Washington State University · NCT05733442
This study is testing a new counseling program to see if it helps people in the Cherokee Nation stick with their opioid treatment better than standard care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 136 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Washington State University (other) |
| Locations | 2 sites (Tahlequah, Oklahoma and 1 other locations) |
| Trial ID | NCT05733442 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of the Counseling for Harm Reduction and Retention in Medication-assisted Treatment (CHaRRM-CN) program specifically designed for the Cherokee Nation. Participants will be randomly assigned to either the CHaRRM-CN program or standard treatment, with follow-ups at 1, 3, and 6 months to assess retention in treatment, substance use outcomes, and cultural connectedness. The study addresses the unique challenges faced by the American Indian population regarding opioid use disorder and seeks to enhance treatment retention through culturally adapted approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have recently registered in the Cherokee Nation Health Services Medication-assisted Treatment Program.
Not a fit: Patients who are unable or unwilling to provide informed consent or who pose a risk to others may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve retention rates in medication-assisted treatment for opioid use disorder among American Indian patients.
How similar studies have performed: While specific studies on opioid treatment outcomes for American Indian populations are limited, culturally adapted treatment approaches have shown promise in reducing substance use and associated harm in Native communities.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. At least 18 years of age 2. Must be newly registered (within 4 weeks) in the CNHS MAT Program. (Prior patients can participate as long as their most recent treatment course was at least 6 months prior). 3. Must be willing to provide written informed consent to enroll in this study Exclusion Criteria: 1. Refusal or inability to consent to participation in research. (The latter is assessed using the UCSD Brief Assessment of Capacity to Consent.) 2. Refusal or inability to consent and constituting a risk to the safety and security of other patients or staff
Where this trial is running
Tahlequah, Oklahoma and 1 other locations
- Cherokee Nation Health Services — Tahlequah, Oklahoma, United States (RECRUITING)
- University of Washington School of Medicine — Seattle, Washington, United States (ACTIVE_NOT_RECRUITING)
Study contacts
- Principal investigator: Lonnie A Nelson, PhD — Washington State University
- Study coordinator: Susan E Collins, PhD
- Email: collinss@uw.edu
- Phone: 2068327885
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Opioid Use Disorder, opioid use disorder, harm reduction, medication assisted treatment, American Indian